Cargando…
Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis
Purpose: Epidermal growth factor receptor (EGFR) mutation is the most common target for precision treatment in metastatic lung adenocarcinoma. We investigated the predictive role of (18)F-FDG PET/CT and clinicopathological features for EGFR mutations in lung adenocarcinoma with bone metastasis. Meth...
Autores principales: | Yao, Guangyu, Zhou, Yiyi, Gu, Yifeng, Wang, Zhiyu, Yang, Mengdi, Sun, Jing, Luo, Quanyong, Zhao, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391209/ https://www.ncbi.nlm.nih.gov/pubmed/32742498 http://dx.doi.org/10.7150/jca.46414 |
Ejemplares similares
-
A Retrospective Study of predicting risk of Metastasis among FDG-avid Bone Lesions in (18)F-FDG PET/CT
por: Yao, Guangyu, et al.
Publicado: (2020) -
Differentially expressed and survival‐related proteins of lung adenocarcinoma with bone metastasis
por: Yang, Mengdi, et al.
Publicado: (2018) -
Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2021) -
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway
por: Yang, Mengdi, et al.
Publicado: (2020) -
The predictive value of (18)F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population
por: Wang, Jian, et al.
Publicado: (2022)